Orkin C, Antinori A, Rockstroh JK, Moreno-Guillen S, et al. Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis. AIDS 2024 Feb 12. doi: 10.1097/QAD.0000000000003865.
PMID: 38349226